This website does not constitute an offer or invitation for the sale or purchase of securities or to engage in any other transaction with Rasna or its affiliates. The information in this presentation is not targeted at the residents of any particular country or jurisdiction and is not intended for distribution to, or use by, any person in any jurisdiction or country where such distribution or use would be contrary to local law or regulation.
No reliance may be placed for any purpose whatsoever on the information or opinions contained in the Website or their completeness, fairness or accuracy. No representation or warranty, expressed or implied, is given on behalf of the Company or any of its respective directors, partners, employees, agents or advisers as to the completeness, fairness or accuracy of the information or opinions contained herein and, save in the case of fraud, no responsibility or liability is accepted (and all such liability is hereby excluded) for any errors, omissions or inaccuracies in such information or opinions.
Viewers of this Website are reminded that none of the information contained in this Website has been verified and the information contained therein is subject to updating, correction, completion, revision and amendment. Any opinions, forecasts or estimates in this Website constitute a judgement as at the date of writing. There can be no assurance that future results or events will be consistent with any such opinions, forecasts or estimates. Viewers of this Website who are considering making an investment in the Securities are reminded that any such purchase must be made solely on the basis of information contained in the admission document issued by the Company which may be different from the information contained in this Website and their own assessment and investigations of the Company and that no assurances or warranties or similar will provided as to the contents of the Website.
This website may contain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Such forward-looking statements are characterized by future or conditional verbs such as “may,” “will,” “expect,” “intend,” “anticipate,” believe,” “estimate” and “continue” or similar words. You should read statements that contain these words carefully because they discuss future expectations and plans, which contain projections of future results of operations or financial condition or state other forward-looking information. Such statements are only predictions and our actual results may differ materially from those anticipated in these forward-looking statements.
We believe that it is important to communicate future expectations to investors. However, there may be events in the future that we are not able to accurately predict or control. Factors that may cause such differences include, but are not limited to, those discussed under Risk Factors and elsewhere in our Annual Report on Form 10-K for the year ended June 30, 2016, as filed with the Securities and Exchange Commission, including the uncertainties associated with product development, the risk that products that appeared promising in early clinical trials do not demonstrate safety and efficacy in larger-scale clinical trials, the risk that we will not obtain approval to market our products, the risks associated with dependence upon key personnel and the need for additional financing. We do not assume any obligation to update forward-looking statements as circumstances change.